dc.contributor.author | Naseri, N | |
dc.contributor.author | Valizadeh, H | |
dc.contributor.author | Zakeri-Milani, P | |
dc.date.accessioned | 2018-08-26T09:35:13Z | |
dc.date.available | 2018-08-26T09:35:13Z | |
dc.date.issued | 2015 | |
dc.identifier | 10.15171/apb.2015.043 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57844 | |
dc.description.abstract | Lipid nanoparticles (LNPs) have attracted special interest during last few decades. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are two major types of Lipid-based nanoparticles. SLNs were developed to overcome the limitations of other colloidal carriers, such as emulsions, liposomes and polymeric nanoparticles because they have advantages like good release profile and targeted drug delivery with excellent physical stability. In the next generation of the lipid nanoparticle, NLCs are modified SLNs which improve the stability and capacity loading. Three structural models of NLCs have been proposed. These LNPs have potential applications in drug delivery field, research, cosmetics, clinical medicine, etc. This article focuses on features, structure and innovation of LNPs and presents a wide discussion about preparation methods, advantages, disadvantages and applications of LNPs by focusing on SLNs and NLCs. © 2015 The Authors. | |
dc.language.iso | English | |
dc.relation.ispartof | Advanced Pharmaceutical Bulletin | |
dc.subject | cosmetic | |
dc.subject | nanomaterial | |
dc.subject | nanostructured lipid carrier | |
dc.subject | solid lipid nanoparticle | |
dc.subject | unclassified drug | |
dc.subject | chemical composition | |
dc.subject | chemical procedures | |
dc.subject | cold homogenization | |
dc.subject | crystallization | |
dc.subject | drug delivery system | |
dc.subject | drug enriched core | |
dc.subject | drug enriched model | |
dc.subject | drug release | |
dc.subject | drug stability | |
dc.subject | food industry | |
dc.subject | gene transfer | |
dc.subject | high pressure homogenization | |
dc.subject | human | |
dc.subject | molecular stability | |
dc.subject | nanofabrication | |
dc.subject | nonbiological model | |
dc.subject | nonhuman | |
dc.subject | oral drug administration | |
dc.subject | particle size | |
dc.subject | pulmonary drug delivery | |
dc.subject | Review | |
dc.subject | scanning electron microscopy | |
dc.subject | solid solution model | |
dc.subject | solvent emulsification | |
dc.subject | solvent evaporation | |
dc.subject | spray drying | |
dc.subject | structure activity relation | |
dc.subject | structure analysis | |
dc.subject | supercritical fluid extraction | |
dc.subject | supercritical fluid extraction of emulsion | |
dc.subject | synthesis | |
dc.subject | transmission electron microscopy | |
dc.title | Solid lipid nanoparticles and nanostructured lipid carriers: Structure preparation and application | |
dc.type | Article | |
dc.citation.volume | 5 | |
dc.citation.issue | 3 | |
dc.citation.spage | 305 | |
dc.citation.epage | 313 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | 10.15171/apb.2015.043 | |